aTyr Pharma reported $-128K in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Ardelyx USD -32.79M 37.89M Mar/2026
aTyr Pharma USD -128K 24.6M Mar/2026
Biogen USD -243.8M 758.1M Jun/2026
Bristol-Myers Squibb USD 299M 3.07B Jun/2026
Cipla INR 8.88B 2.74B Jun/2026
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD -9.02M 65.06M Mar/2026
CSL USD 2.64B 1.97B Dec/2025
Curis USD -11.52M 3.64M Mar/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
Grifols EUR 320.55M 91.01M Dec/2025
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Novartis USD 4.75B 515M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
United Therapeutics USD 330.8M 5M Jun/2026